Status:
COMPLETED
Action of Probiotics on the Microbiota and Intestinal Permeability in Children With Neurodevelopmental Disorders and Their Influence on the Improvement of Language and Learning
Lead Sponsor:
Instituto de Genética Médica y Molecular
Collaborating Sponsors:
Industrial Farmacéutica Cantabria, S.A.
Conditions:
Neurodevelopmental Disorders
Eligibility:
All Genders
3-16 years
Brief Summary
The study included boys and girls with neurodevelopmental disorders between the ages of 3 and 16 years, belonging to two educational centers in Madrid, attended by children with this type of disorder....
Detailed Description
The trial was conducted in 4 stages: * Probiotic development, which will be randomized, so that some children will receive the probiotic and others placebos, and blinded, so that neither the children...
Eligibility Criteria
Inclusion
- Children with neurodevelopmental disorders between 3 and 16 years old
- Similar characteristics in terms of type of food
Exclusion
- Digestive symptomatology: gastroesophageal reflux, abdominal pain, flatulence, dysphagia, abdominal distension or constipation
Key Trial Info
Start Date :
October 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2022
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06200935
Start Date
October 1 2021
End Date
October 1 2022
Last Update
January 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mencía Hermosa Vicente
Madrid, Spain, 28043